ADVERUM BIOTECHNOLOGIES INC (ADVM)

US00773U2078 - Common Stock

9.74  +0.21 (+2.2%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
3.60M0.007.50M0.00250.00K
Operating Expenses
127.39M155.04M152.52M117.95M68.80M
Research and Development
77.68M99.28M89.18M73.31M40.42M
Selling, General, and Administrative Expenses
49.72M55.76M63.34M44.64M28.38M
Operating Income
-123.79M-155.04M-145.02M-117.95M-68.55M
Interest Income/Expense
N/AN/AN/AN/AN/A
Other Income/Expense
5.75M2.67M580.00K1.56M4.06M
Non Recurring Items
-200.00K-2.10M-1.10M0.00N/A
Income Before Taxes
-118.24M-154.46M-145.54M-116.39M-64.49M
Income Tax
-1.08M70.00K0.001.11M0.00
Net Income
-117.17M-154.54M-145.54M-117.51M-64.49M
EBITDA
-118.15M-148.51M-140.37M-113.79M-66.98M
 
Per Share Data
EPS Diluted Total Ops
-11.62-1.56-1.48-1.38-1.01
Non GAAP EPS
-8.99-1.55-1.48-1.37-1.00
 
Statistics
Profit Margin
-3254.58%N/A-1940.53%N/A-25796.00%
Operating Profit Margin
-3438.64%N/A-1933.60%N/A-27420.00%

All data in USD

Charts